Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We utilise our cutting-edge, exclusive workflow to develop focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
This approach involves comprehensive molecular simulations of the catalytic and allosteric binding pockets and ensemble virtual screening that accounts for their conformational flexibility. In the case of designing modulators, the structural adjustments caused by reaction intermediates are considered to improve activity and selectivity.
Our library stands out due to several important features:
partner
Reaxense
upacc
Q9NQR9
UPID:
G6PC2_HUMAN
Alternative names:
Islet-specific glucose-6-phosphatase catalytic subunit-related protein
Alternative UPACC:
Q9NQR9; E9PAX2; Q6AHZ0
Background:
Glucose-6-phosphatase 2, also known as the islet-specific glucose-6-phosphatase catalytic subunit-related protein, plays a crucial role in glucose metabolism. It is believed to hydrolyze glucose-6-phosphate to glucose within the endoplasmic reticulum, facilitating glucose production through glycogenolysis and gluconeogenesis. This protein's activity is essential for maintaining glucose homeostasis, a critical aspect of metabolic health.
Therapeutic significance:
Understanding the role of Glucose-6-phosphatase 2 could open doors to potential therapeutic strategies. Its involvement in glucose metabolism makes it a significant target for addressing metabolic disorders, offering a promising avenue for the development of treatments aimed at enhancing metabolic health.